Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Enveric Biosciences Signed Two Non-binding Term Sheets With An Undisclosed Biotechnology Company To Pursue The Out-licensing Of Cannabinoid-COX-2 Conjugate Compounds For Pharmaceutical And Non-pharmaceutical Applications For Joint Diseases For $82M

Author: Benzinga Newsdesk | March 19, 2024 07:05am

Posted In: ENVB